Back
Aclaris Therapeutics Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
26
ACRS
Aclaris Therapeutics
Last Price:
1.25
Seasonality Move:
-2.56%
Buy
56
ANIP
ANI Pharmaceuticals
Last Price:
65.45
Seasonality Move:
3.68%
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.23. The Score for ACRS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $64.59. The Score for ANIP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.23
The current trend is relatively stagnant and ACRS is experiencing slight selling pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $64.59
The current trend is moderately bearish and ANIP is experiencing selling pressure, which indicates risk of future bearish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 52.33 | Buy |
| Chaikin Money Flow: | -126508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.24) | Buy |
| Bollinger Bands (100): | (1.02 - 1.26) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 39.88 | Sell |
| Chaikin Money Flow: | -124786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.13 - 68.93) | Sell |
| Bollinger Bands (100): | (52.66 - 65.58) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Buy |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.22 | Buy |
| 200-day SMA: | 4.05 | Sell |
| 8-day EMA: | 1.22 | Buy |
| 20-day EMA: | 1.21 | Buy |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 3.78 | Sell |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.34 | Sell |
| 20-day SMA: | 67.63 | Sell |
| 50-day SMA: | 64.42 | Buy |
| 200-day SMA: | 58.34 | Buy |
| 8-day EMA: | 66.09 | Sell |
| 20-day EMA: | 66.61 | Sell |
| 50-day EMA: | 64.53 | Buy |
| 200-day EMA: | 57.53 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.05 per share, and an increase next year of $0.57 per share.
Aclaris Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||